Summary
- Current Price
- As of today, IKT price is $1.63, up +5.16% on
- Current Price All-Time High
- IKT price is currently -97.70% below its historical high of $70.80 set on
- Market Cap
- IKT current market cap is $227M, up +85.39% over the past 365 days
- Revenue
- IKT current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for IKT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Inhibikase Therapeutics, Inc. |
| Ticker | NASDAQ: IKT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | inhibikase.com |
| Employees | 15 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.63 | ||
| Price, 1D Change | +5.16% | |
| $227M | ||
| - | ||
| - | ||
| 1.57 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.49 | ||
| EPS, 1Y Change | +57.70% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:6 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.49 | ||
| EPS Estimate | -$0.40 | N/A |
| EPS Est. Change | +18.52% | N/A |
| $0.00 | ||
| Revenue Estimate | $187.50K | N/A |
| Revenue Est. Change | - | N/A |
| $1.63 | ||
| Price Target | $5.50 | - |
| Price Tgt. Change | +237.42% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.90 | -$1.16 | -28.48% | |
| -$0.51 | -$0.49 | +4.55% | |
| -$0.40 | N/A | +18.52% | |
| -$0.42 | N/A | +14.44% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $187.50K | N/A | - | |
| $250.00K | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -0.61% | ||
| +63.00% | ||
| +85.39% | ||
| +4,143.11% | ||
| 0.00% | ||
| -100.00% | ||
| +57.70% | ||
| +88.57% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.63 | ||
| $1.93 | ||
| $1.94 | ||
| $1.93 | ||
| $1.83 | ||
| -$0.10 | ||
| 1.57 | ||
| $0.12 | ||
| 46.70 | ||
| 108.55% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$0.49 | ||
| -$60.50K | ||
| - | ||
| -$53.35M | ||
| - | ||
| -$48.26M | ||
| - | ||
| -$53.29M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 21.70 | ||
| 21.70 | ||
| - | ||
| - | ||
| 15.50 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 1.20 | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $172.90M | ||
| $178.76M | ||
| $181.20M | ||
| $180.11M | ||
| $8.30M | ||
| $8.30M | ||
| $0.00 | ||
| $0.00 | ||
| $1.16M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $48.26M | ||
| $53.29M | ||
| $60.50K | ||
| $0.00 | ||
| $60.50K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$27.79M | ||
| $2.05M | ||
| $108.46M | ||
| $13.40K | ||
| -$27.80M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Chardan Capital | ||
| Oppenheimer | ||
| Ladenburg Thalmann | ||
| B of A Securities | ||
| Freedom Broker | ||
| Cantor Fitzgerald | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Jefferies | ||
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with IKT
FAQ
- What is the ticker symbol for Inhibikase Therapeutics, Inc.?
- The ticker symbol for Inhibikase Therapeutics, Inc. is NASDAQ:IKT
- Does Inhibikase Therapeutics, Inc. pay dividends?
- No, Inhibikase Therapeutics, Inc. does not pay dividends
- What sector is Inhibikase Therapeutics, Inc. in?
- Inhibikase Therapeutics, Inc. is in the Healthcare sector
- What industry is Inhibikase Therapeutics, Inc. in?
- Inhibikase Therapeutics, Inc. is in the Biotechnology industry
- What country is Inhibikase Therapeutics, Inc. based in?
- Inhibikase Therapeutics, Inc. is headquartered in United States
- When did Inhibikase Therapeutics, Inc. go public?
- Inhibikase Therapeutics, Inc. initial public offering (IPO) was on December 23, 2020
- Is Inhibikase Therapeutics, Inc. in the S&P 500?
- No, Inhibikase Therapeutics, Inc. is not included in the S&P 500 index
- Is Inhibikase Therapeutics, Inc. in the NASDAQ 100?
- No, Inhibikase Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Inhibikase Therapeutics, Inc. in the Dow Jones?
- No, Inhibikase Therapeutics, Inc. is not included in the Dow Jones index
- When was Inhibikase Therapeutics, Inc. last earnings report?
- Inhibikase Therapeutics, Inc.'s most recent earnings report was on August 11, 2026
- When does Inhibikase Therapeutics, Inc. report earnings?
- The next expected earnings date for Inhibikase Therapeutics, Inc. is November 13, 2026
Data Sources & References
- IKT Official Website www.inhibikase.com
- IKT Profile on Yahoo Finance finance.yahoo.com/quote/IKT
- IKT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ikt